AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03264118 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Description: Furcation treatment by scaling and root planing
Study NCT03264118 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing
Description: Furcation treatment by scaling and root planing
Study NCT03264118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toluidine Blue O
Description: Antimicrobial photodynamic therapy with toluidine blue O (10mg/ml) and red laser.
Study NCT04143178 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expressive Writing
Description: The expressive writing is a form of writing therapy developed primarily by James W. Pennebaker in the late 1980s consisting of writing about stressful and traumatic experience for 15-20 min for 3 consecutive days, including one's thoughts and feelings. The expressive writing allows people to express and process emotions, feelings, and thoughts related to the life events and consequent changes and this may favor a mental reorganization of the negative events, a greater expression and regulation of the emotions related to them. This intervention could provoke social, emotional, and consequently, psychophysical changes as is showed in patients with chronic diseases and cancer. In the present study, to all participants in the writing group, 5 days after the transplant, has been asked to write for 3 consecutive days, 20 minutes each days about their deepest emotions and feelings related to the chronic failure, the transplant and their expectations after that.
Study NCT04143178 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neutral Writing
Description: Five days after the transplant, to the control group participants has been asked to write for 3 consecutive days 20 minutes a day on an assigned neutral theme (eg. describe 1 object in the room) as objectively as possible, without mentioning their emotions or thoughts related to it.
Study NCT02482831 — intervention group
Intervention type: PROCEDURE
Intervention: Subgluteal sciatic nerve block
Description: All patients (either diabetic or non-diabetic patients) received an ultrasound-guided (nerve stimulator assisted) subgluteal sciatic nerve block with 0.75% ropivacaine 20ml.
Study NCT02084251 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PB-119
Study NCT04234256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching exercise
Description: Standing quadriceps stretch, Gastrocnemius stretch, Standing split, Adductor stretch, Half kneeling groin stretch, Hamstring stretch on the bench, Prayer squat, Seated adductor and hamstring stretch, Hurdle seat, Seated glute stretch, Lying glute stretch, Seated groin abduction, Soleus stretch, Half kneeling quad stretch, Split hamstring stretch
Study NCT04234256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic stretching exercise
Description: Downward dog to runner's lunge, Dynamic squat stretch, Crescent to hamstring stretch, Half kneeling hamstring stretch, Side to side lunge with reach, Standing calf and hamstring stretch, Hurdles, Side to side lunge with step, IT band stretch, Walking quad stretch, Swing the leg forward and back, Swing the leg cross, Knee pull, Standing quat stretch, Standing gluteus stretch
Study NCT04121364 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetranite
Description: Dental Adhesive for increased implant stability
Study NCT04507425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care - Nasal Cannula
Description: Standard of care. Flexible tube to provide extra oxygen when patients need a little help, but are not in respiratory distress.
Study NCT04507425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-flow nasal cannula
Description: Same as nasal cannula, except the oxygen is heated or humidified and the flow is stronger, pushing air into the lungs to help keep the airway open.
Study NCT02435914 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AGN-223575 vehicle ophthalmic solution
Description: Vehicle to AGN22375 ophthalmic solution once or twice daily.
Study NCT03038347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training
Description: Six modules containing PDF-files with text-based information, video files, case studies with associated questions and practical exercises. Participants can download the modules and associated materials from an online platform they need to register for. They receive access to modules and associated exercises once a week. After six weeks the training is completed.
Study NCT00348608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iodixanol
Study NCT04507425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HFNC plus non-invasive ventilation
Description: This method uses HFNC as described above and adds noninvasive ventilation which is similar to CPAP machine and uses a mask rather than having to intubate (putting a tube down your throat to keep your airway from collapsing).
Study NCT02433106 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GAA 15
Description: Neuromuscular injury prevention training
Study NCT02433106 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Usual training
Study NCT01135927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec
Description: NN1250 (insulin degludec) injected s.c. (under the skin) once daily for 6 days
Study NCT01135927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin detemir
Description: Insulin detemir injected s.c. (under the skin) once daily for 6 days
Study NCT02072486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02072486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib Tosylate
Description: Given PO
Study NCT01851577 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Foundations coparenting program
Description: Family Foundations is a coparenting program for new mothers and fathers designed to teach them skills needed to parent together effectively and facilitate healthy child development. Family Foundations will be administered concurrently with home visiting.
Study NCT01851577 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home visiting
Description: Home visiting is a child abuse prevention approach for new mothers designed to strengthen protective factors and mitigate risk factors in order to promote optimal child development.
Study NCT00535860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Description: Daily for 96 days
Study NCT00535860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Daily for 96 days
Study NCT00681356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4975, 15 and 5 mg
Description: Direct instillation into the surgical site
Study NCT00681356 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Direct instillation into the surgical site
Study NCT00336479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaprevir
Description: tablet
Study NCT03038347 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education only
Description: Six modules containing only PDF-files with text-based information. Participants can download the modules and associated materials from an online platform they need to register for. They receive access to modules once a week. After six weeks the education is completed.
Study NCT04586829 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet
Description: \<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.
Study NCT04586829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: \<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.
Study NCT00336479 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ribavirin
Description: tablet
Study NCT00681356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4975 - 5 mg
Description: Direct instillation into the surgical site
Study NCT00502203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 5 By Vein Over 1 Hour Every 21 Days for 6 Courses
Study NCT00502203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175 mg/m\^2 By Vein Over 3 Hours Every 21 Days for 6 Courses
Study NCT02505529 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training
Description: Behavioral interventions of resistance exercise
Study NCT02505529 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Imagery
Description: Behavioral intervention of mental imagery
Study NCT02476318 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArterX Vascular Sealant
Study NCT03640832 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Developmental Serum
Description: A 30millilitre (mL) bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.
Study NCT03640832 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiogel Calming Relief Anti-Redness Serum
Description: A 30mL bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.
Study NCT01911026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reinforcement Nurse Education
Description: The investigational, or experimental arm, will receive standard written instructions on preparing for a colonoscopy plus instructions from reinforcement educated nurse
Study NCT03498157 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: The exercise intervention is an at least 2 weeks lasting (till the day surgery is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking).
Study NCT03498157 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise intervention is an at least 2 weeks lasting (till the day surgery is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking).
Study NCT03498157 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prehabilitation Education
Description: Participate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey
Study NCT03498157 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehabilitation Education
Description: Participate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey
Study NCT01318122 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin and pioglitazone
Description: Alogliptin 12.5 mg, tablets, orally, once daily and Pioglitazone 15 mg or 30 mg, tablets, orally, once daily for up to 40 weeks.
Study NCT01318122 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin and pioglitazone
Description: Alogliptin 25 mg, tablets, orally, once daily and Pioglitazone 15 mg or 30 mg, tablets, orally, once daily for up to 40 weeks.
Study NCT03573713 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Care Groups
Description: The Care Groups model has strong evidence of improvement of maternal and child health and maternal hygiene/nutrition behaviors.Through Care Groups, women will learn about proper water, sanitation, and hygiene behaviors; Infant and Young Child Feeding practices; management of childhood illnesses; home management, referral and care seeking for sick children; family planning; and use of preventive services available at health facilities (e.g., growth monitoring, deworming, vitamin A supplementation). All children under five years of age will also be screened for acute malnutrition by the Care Group Volunteers, and receive deworming medication and vitamin A supplementation twice a year through the Ministry of Health and Community Health Workers as part of national campaigns.
Study NCT03573713 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPT-G
Description: IPT-G is an effective, low-cost, short-duration community-based method for decreasing depression has been established that was first rigorously tested in Uganda. Several Private Voluntary Organizations in Africa have used this low-cost, short-duration, community-based group psychosocial approach and found it to be a culturally-sensitive, acceptable, and feasible approach to address depression.~IPT-G treatment spans 12 weeks of treatment, consisting of 3 phases (early, middle, and termination). Within this treatment, participants are also assessed for symptoms of depression every week.
Study NCT01319604 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 1
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 2
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 3
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 4
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 5
Study NCT02170116 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to BIBR 1048 MS
Study NCT01319604 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tonometer
Description: Tonometric assessment of IOP
Study NCT03614208 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-care rehabilitation group (HCRG)
Description: The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.
Study NCT03891797 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy
Description: Group-based psychotherapy.
Study NCT03312569 — intervention group
Intervention type: PROCEDURE
Intervention: Right Colectomy with Intracorporeal Anastomosis
Description: With the patient under general anesthesia, pneumoperitoneum is achieved by a method of choice of the operating surgeon. Port Placement is completed as per the standard of care. Dissection is performed and the ileocolic vessels are identified. The right mesocolon is mobilized and the ileal mesentery is divided. The transverse colon and ileum are then divided with the stapler. Next, attention is turned to constructing the anastomosis. For this purpose, the terminal ileum and the transverse colon stump are brought together. A colotomy and ileostomy is created to form a common channel. The common enterotomy is then closed as per the surgeon's standard of care. The specimen is extracted through an off-midline incision (muscle splitting transverse incision, Pfannenstiel).
Study NCT03312569 — intervention group
Intervention type: PROCEDURE
Intervention: Right Colectomy with Extracorporeal Anastomosis
Description: With the patient under general anesthesia, pneumoperitoneum is achieved by a method of choice of the operating surgeon. Port Placement is completed as per the standard of care. Dissection is performed and the ileocolic vessels are identified. Intracorporeal devascularization may be performed at the surgeon's discretion. The gastrocolic ligament is taken down and the hepatic flexure is mobilized. After complete mobilization of the right colon, the midline incision is extended to serve as the extraction site. The specimen is delivered through the midline extraction incision and the anastomosis is conducted in a standard open technique. The two cut ends of the bowels are aligned for extracorporeal anastomosis.
Study NCT01857609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Study NCT03542032 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: i-gel placement maneuvers
Description: the i-gel was inserted with triple airway maneuver (mouth opening, head extension and jaw thrust) In the classic maneuver , the index finger used as a guide, pushes the back of i-gel towards the hard palate, inserting it into the pharynx till a resistance is felt and the i-gel is then fixed it its place.
Study NCT01423188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RVX000222
Description: capsule, 200 mg, administer with food, 100 mg twice daily 10-12 hrs apart, 24 weeks
Study NCT01423188 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo RVX000222
Description: capsule, administer with food, twice daily 10-12 hrs apart, 24 weeks
Study NCT01857609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin and Pantoprazole
Study NCT01857609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin and Rabeprazole
Study NCT02509091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar Lavage and Local Amikacin Injection
Description: injecting 0.4g of AK in 100 ml to 250 ml, not exceeding 300 ml. And generally, repeat it for 3 to 5 times.
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod Placebo
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin Placebo
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 10 mg
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 20 mg
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 40 mg
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 60 mg
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 80 mg
Study NCT00336479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: tablet
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 100 mg
Study NCT02136888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Study NCT04786834 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vesico urethral anastomosis on chicken model
Description: Performance of a vesico urethral anastomosis on a chicken model with Da Vinci robotic system
Study NCT04786834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vesico urethral anastomosis on chicken model
Description: Performance of a vesico urethral anastomosis on a chicken model with Da Vinci robotic system
Study NCT02601261 — intervention group
Intervention type: OTHER
Intervention: At the first day of hospitalization the field investigator will submit to pregnant women in a pathological condition five questionnaires
Description: Some of these questionnaires will have to be completed every day and others every other day:~1. The Internet questionnaire is divided in two parts. The first one investigates the use of internet at home and it will be administered only once, the second part will investigate the internet use at the hospital, in the case the women have a personal smartphone, tablet or personal computer (they are the owners) and it will be administered every other days.~2. The questionnaire is aimed to understand the quality of life (EQ-5D) will be administered only once, at the beginning of the hospitalization.~3. The STAI questionnaire is divided in to parts, the first part aims to determinate the state anxiety and it will be administered every other day, while the second part will discuss the anxiety itself, and has to completed only once.~4. The short questionnaire on critical events occurring during the day,~5. The short questionnaire with obstetric anamnesis.
Study NCT00336479 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pegylated Interferon Alfa 2a
Description: Solution for injection
Study NCT00336479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated Interferon Alfa 2a
Description: Solution for injection
Study NCT02663934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The resistance exercise training component will follow aerobic exercise and will consist of 4 upper and 3 lower body routines. A combination of guided-motion machines and free weights will be used. Voluntary maximum strength will be measured during the first 4 sessions on each exercise station. The program will initially consist of 1-2 sets of each exercise while lifting a weight that causes muscle fatigue after 8-10 repetitions. The trainer will monitor each participant's exercise response, and when the participant can comfortably lift the weight for 12 repetitions on any exercise, the weight will be increased to cause the muscle group to fatigue after 8 repetitions. This progressive 8-12 repetition cycle is repeated for each exercise over 26 weeks.
Study NCT02663934 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stretching and Social Interaction
Description: Participants will receive instructions on stretching, range of motion, limbering, and toning. Activities will focus on flexibility enhancement. Along with the stretching and flexibility, this group will have a social interaction component. They will have discussions and interact with trainers and coordinators during all their sessions. These participants will be supervised by the same trainer and will receive the same amount of attention and class interaction as participants in the EXS program.
Study NCT00125606 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conditioning for allogeneic HSCT